Background: Chronic rhinosinusitis (CRS) with nasal polyps (NPs) in Western populations is associated with T H 2 cytokine polarization. IL-25, an IL-17 family cytokine, was recently reported to induce T H 2-type immune responses and to contribute to several allergic diseases, such as atopic dermatitis and asthma. However, the role of IL-25 in Asian patients with nasal polyposis remains unclear. Objective: We sought to determine the role of IL-25 in Asian patients with nasal polyposis and CRS. Methods: We investigated IL-25 expression and its cellular origins in NPs of human subjects using immunohistochemistry (IHC), quantitative RT-PCR, and ELISA of NP tissues. Correlations between IL-25 expression and expression of other inflammatory markers in NP tissues were also explored. Anti-IL-25 neutralizing antibody was administered in an ovalbumin-and staphylococcal enterotoxin B-induced murine NP model to confirm the function of IL-25 during nasal polypogenesis. Results: IL-25 expression was upregulated in NP mucosa from patients with CRS with NPs compared with uncinate process tissue from control subjects and those with CRS without NPs. Overexpression of epithelial IL-25 was confirmed by using IHC, and double IHC staining showed that tryptase-positive cells were one of the main sources of IL-25 among immune cells. Furthermore, IL-17 receptor B levels were also increased in immune cells of patients with NPs compared with those in control subjects. In NPs IL-25 mRNA expression positively
Chronic rhinosinusitis (CRS) is a common upper airway disease that affects 5% to 16% of the population worldwide. [1] [2] [3] CRS is characterized by chronic inflammation of the sinonasal mucosa that persists for at least 12 weeks despite medical treatment. 2 Nasal polyps (NPs) frequently accompany CRS, and their occurrence indicates a more serious illness with recurrent clinical phenotypes. 4, 5 Chronic rhinosinusitis with nasal polyps (CRSwNP) in Western populations is associated with T H 2 cytokine polarization and prominent eosinophilic infiltration. 6 Thus upstream mechanisms that incite the T H 2 response are crucial for understanding the pathogenesis of CRSwNP 7 ; however, these mechanisms are not fully understood.
IL-25 (also known as IL-17E) is a member of the IL-17 cytokine family and has been reported to play a variety of roles in different inflammatory murine models, such as asthma, atopic dermatitis, and pulmonary fibrosis. Intraperitoneal or intranasal administration of IL-25 protein resulted in the production of eosinophils or T H 2 cytokines, such as IL-4, IL-5, IL-13, and eotaxin, in bronchoalveolar lavage fluid and lung tissue. 8, 9 Conversely, blocking IL-25 decreases T H 2 cytokine production in an animal model of asthma. [10] [11] [12] In addition, IL-25 could function in patients with allergic dermatitis by inducing the T H 2 response, as well as by inhibiting filaggrin synthesis, consequently affecting skin barrier function. 13, 14 Apart from allergic diseases, IL-25 also plays an important role in different inflammatory conditions. One recent study showed that expression of IL-25 was increased and correlated with levels of periostin, an extracellular matrix protein, in patients with idiopathic pulmonary fibrosis. 15 Moreover, this study demonstrated that IL-25 can drive fibrosis, which was confirmed by a decrease in collagen deposition in IL-25-deficient animal models. 15 Collectively, these data indicate that IL-25 is a potent cytokine that acts in diverse inflammatory conditions.
Recently, IL-25 and IL-33, which are both produced by sinonasal epithelial cells, were reported to have critical roles in promoting T H 2-mediated inflammation. 16 Induction of IL-33, a member of the IL-1 cytokine family, has been observed in epithelial cells from patients with CRSwNP. IL-33 induction also stimulates IL-13 production in ST2
1 innate lymphoid cells from NPs. 17 IL-25 enhances thymic stromal lymphopoietininduced T H 2 cell expansion and function. 18 Although one study reported that increased IL-25 levels correlated with poorer computed tomographic (CT) scores and increased serum eosinophil numbers in sinus mucosal tissues in patients with CRS, thus suggesting a relationship between IL-25 and T H 2-dominant diseases, 19 the specific role of IL-25 in Asian patients with CRSwNP has not been thoroughly explored. In this study we investigated the expression and cellular origin of IL-25, as well as correlations between IL-25 and inflammatory surrogates in sinonasal tissues from patients with CRSwNP. We also evaluated the effects of anti-IL-25 therapy on nasal polyp formation in an NP-induced murine model. Some results of this study have been previously reported in the form of an abstract. 20 
METHODS

Patients and tissue samples
Sinonasal and polyp tissues were obtained from routine functional endoscopic sinus surgery in patients with CRS. CRS diagnoses were based on personal medical history, physical examination, nasal endoscopy, and CT findings of the sinuses according to the ''EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012'' guidelines. 21 Patients were excluded if they were (1) younger than 18 years old; (2) asthmatic or aspirin sensitive; (3) previously treated with antibiotics, systemic or topical corticosteroids, or other immune-modulating drugs up to 4 weeks before surgery; and (4) afflicted with conditions, such as unilateral rhinosinusitis, antrochoanal polyps, allergic fungal rhinosinusitis, cystic fibrosis, or immotile ciliary disease. Control tissues were obtained from patients without any sinonasal disease during other rhinologic surgeries, such as skull base, lacrimal duct, or orbital decompression surgery. We also obtained uncinate process (UP) tissue from control subjects and patients with CRS, including those with chronic rhinosinusitis without nasal polyps (CRSsNP) and those with CRSwNP. We also evaluated NPs in patients with CRSwNP. Each sample obtained was divided into 3 parts: one part was fixed in 10% formaldehyde and embedded in paraffin for histologic analyses, another part was immediately frozen and stored at 2808C for subsequent isolation of mRNA and proteins, and the third part was submersed in 1 mL of PBS supplemented with 0.05% Tween 20 (Sigma-Aldrich, St Louis, Mo) and 1% PIC (SigmaAldrich) per 0.1 g of tissue. This tissue was homogenized with a mechanical homogenizer at 1000 rpm for 5 minutes on ice. After homogenization, the suspensions were centrifuged at 3000 rpm for 10 minutes at 48C. Supernatants were separated and stored at 2808C for further analysis of cytokines and other inflammatory mediators. 22 The atopic status of study patients was evaluated by using the ImmunoCAP assay (Phadia, Uppsala, Sweden), which detects IgE antibodies against 6 mixtures of common aeroallergens (house dust mites, molds, trees, weeds, grass, and animal dander). Patients were considered atopic if the allergen-specific IgE level was greater than 3.51 kU/L. The diagnosis of asthma and aspirin sensitivity was performed by an allergist based on lung function and challenge tests. Lund-Mackay CT scores and Lund-Kennedy endoscopic scores were obtained before surgery and 6 months after surgery, respectively (Table I ).
All patients provided written informed consent for study participation. This study was approved by the Internal Review Board of Seoul National University Hospital, Boramae Medical Center (no. 06-2012-109).
Immunohistochemistry
Paraffin sections were treated with 3% hydrogen peroxide (H 2 O 2 ) and then incubated with primary antibodies and biotinylated secondary antibodies. Immune complexes were visualized with the Vectastatin ABC Kit (Vector Laboratories, Burlingame, Calif). The numbers of positive cells in epithelia, glands, and submucosa were counted in the densest tissue region in 5 high-power fields (hpfs; 3400 magnification) by 2 independent observers, and average values were scored. Detailed immunohistochemistry (IHC) procedures are described in the Methods section in this article's Online Repository at www.jacionline.org.
Quantitative real-time RT-PCR for inflammatory markers
The mRNA levels of IL-25, T-box transcription factor (T-bet), GATA3, RAR-related orphan receptor C (RORC), eosinophil cationic protein (ECP), TGF-b1, TGF-b2, and several cytokines and chemokines in human NP tissues, mouse nasal tissues, or both were evaluated by using semiquantitative real-time PCR analysis, as previously described. 23 Detailed semiquantitative real-time PCR conditions are described in the Methods section in this article's Online Repository. 
Cytokines from nasal lavage fluid
Nasal lavage was performed, as previously described. 24 After partial tracheal resection during deep anesthesia, a micropipette was inserted into the posterior choana through the tracheal opening in the direction of the upper airway. Each nasal cavity was gently perfused with 200 mL of PBS, and fluid from the nostril was collected and centrifuged. Supernatants were stored at 2808C. IL-4, IL-17A, IFN-g, IL-10, and TGF-b1 levels in nasal lavage fluid were measured with ELISA kits purchased from BioLegend (San Diego, Calif). The lower detection limits of these ELISA kits were 0.5 pg/mL for IL-4, 2.7 pg/mL for IL-17A, 8 pg/mL for IFN-g, 2.7 pg/mL for IL-10, and 2.3 pg/mL for TGF-b1.
Immunoblotting assays
Proteins were electrophoresed on SDS-PAGE and transferred to Immobilon-P membranes. Membranes were incubated with primary antibodies, incubated with horseradish peroxidase-conjugated secondary antibodies, and visualized by using the ECL reaction (GE Healthcare, Hatfield, United Kingdom). The primary antibodies against IL-25 and b-tubulin were purchased from Abcam (Cambridge, United Kingdom) and Santa Cruz Biotechnology (Dallas, Tex), respectively.
Statistical analysis
Statistical analyses used in this study include the Kruskal-Wallis test and the Mann-Whitney U test with the 2-tailed test for unpaired comparisons and were performed with IBM SPSS 20 (SPSS, Chicago, Ill) and GraphPad Prism 6.0 (GraphPad Software, La Jolla, Calif) software. When comparisons were made between groups, Kruskal-Wallis tests were used to establish significant intergroup variability. Mann-Whitney U tests (2-tailed) were then used for between-group comparisons. Pearson correlations were used to determine variable relationships. If not normally distributed, the Spearman correlation coefficient was selected. A P value of less than .05 was considered statistically significant.
RESULTS
IL-25 expression and cellular origin in patients with CRSwNP
Tissues were collected from patients with CRSsNP (UP tissues), patients with CRSwNP (NP and UP tissues), and control subjects (UP tissues) to measure IL-25 expression in patients with CRSwNP. IL-25 expression was greater in epithelial cells of NPs compared with those of UPs in patients with CRSsNP and control subjects (Fig 1, A and B) . We documented a significant increase in IL-25
1 inflammatory cell numbers in NPs and UPs of patients with CRSwNP compared with those in UPs from control subjects and patients with CRSsNP (Fig 1, C , and see Fig E1 in this article's Online Repository at www.jacionline.org). We also examined the expression of IL-25 mRNA in each tissue and found that IL-25 mRNAs levels were significantly higher in NP and UP tissues from patients with CRSwNP than UP tissues from the other patient groups (Fig 1, D) . IL-25 concentrations were measured by using ELISA to examine this observation at the protein level. These data demonstrated that IL-25 protein levels were significantly increased in NP tissue homogenates from patients with CRSwNP compared with those in control tissues (Fig 1,  E) . We used double IHC staining to identify IL-25 1 cells in the subepithelial layer (Fig 1, F , and 2D7 1 cells, was 0 to 23 (median, 5/hpf; n 5 7), 0 to 12 (median, 3/hpf; n 5 7), 3 to 13 (median, 4/hpf; n 5 7), and 0 to 13 (median, 6/hpf; n 5 7), respectively. Collectively, our data show that human NPs had increased IL-25 expression in epithelial cells and partly in infiltrating inflammatory cells, including mast cells and eosinophils.
IL-17RB expression in patients with CRSwNP
IL-25 was previously reported to bind and signal through IL-17RB (also known as IL-17BR or IL-17Rh1), a member of the IL-17R family of cytokine receptors. 25, 26 Therefore we measured IL-17RB expression in nasal tissues from control subjects, patients with CRSsNP, and patients with CRSwNP. IL-17RB 1 inflammatory cell counts were significantly increased in both patients with CRSsNP and those with CRSwNP compared with those in control subjects (Fig 2, A and B) . IL-17RB protein levels were significantly greater in NP tissue homogenates from patients with CRSwNP compared with those in control subjects (Fig 2, C) .
Correlations between IL-25 mRNA expression and other inflammatory markers in human NP tissues
To investigate the implication of upregulated IL-25 expression in patients with CRSwNP, we examined whether IL-25 (Fig 4, B-D and G, and see Fig E4, A and D, in this article's Online Repository at www.jacionline.org). We also observed decreased numbers of eosinophils and neutrophils in the POLYP1aIL-25 group compared with the untreated POLYP group (Fig 4, E and F , and see Fig E4, B and C). Although steroid treatment had anti-inflammatory effects on the nasal mucosa, the anti-IL-25 antibody exerted a stronger effect on eosinophilic recruitment than the steroid treatment (Fig 4, E) . However, the anti-IL-25 antibody had a minor inhibitory effect on goblet cell hyperplasia compared with steroid therapy (Fig 4, H, and see Fig E4, E) .
Alterations in cytokine profiles after IL-25 inhibition
Both anti-IL-25 and steroid therapy suppressed IL-25 expression in the mouse model (Fig 5, A and B) , and cytokine profiles of nasal lavage fluid samples reflected the histologic findings (Fig 5, C) . Anti-IL-25 treatment also reduced IL-4, IFN-g, and TGF-b1 levels in nasal lavage fluid from mice. Level of IL-10, an anti-inflammatory cytokine, were increased by steroid therapy but not by anti-IL-25 treatment. These data suggest that the anti-polyp effect of anti-IL-25 treatment might have a different mechanism from the anti-inflammatory effect of the steroid.
FIG 2. Expression of IL-17RB in patients with CRSwNP or those with CRSsNP.
A, Control UP mucosa from patients without nasal diseases, UPs from patients with CRSsNP, and NP tissues from patients with CRSwNP were immunostained with IL-17RB antibody. Negative controls were immunostained with isotype IgG. B, Comparison of IL-17RB expression in each tissue (n 5 6 for control-UP, n 5 9 for CRSsNP-UP, n 5 11 for CRSwNP-UP, and n 5 13 for CRSwNP-NP). Expression levels of IL-17RB were reviewed under the hpf (magnification 3400). The final score of each sample is presented as the average of scores from the 5 densest areas (hpf; magnification 3400). C, Protein levels of IL-17RB were measured by means of ELISA and compared (n 5 9 for control-UP, n 5 15 for CRSsNP-UP, n 5 15 for CRSwNP-UP, and n 5 15 for CRSwNP-NP). *P < .05, **P < .01, and ***P < .001, Mann-Whitney U test.
Alterations in chemokine and adhesion molecule expression after IL-25 inhibition
Eosinophil chemotactic chemokines (CCL11 and CCL24), neutrophil-recruiting chemokines (CXCL1 and CXCL2), and recruitment adhesion molecules (E-selectin, intercellular adhesion molecule [ICAM] 1, and vascular cell adhesion molecule [VCAM] 1) were assessed in mice with NPs to verify that inflammatory cell recruitment was inhibited by anti-IL-25 treatment. These chemokines and adhesion molecules were upregulated when NPs were induced in mice (Fig 6) ; however, IL-25 inhibition led to downregulation of chemotactic factors (CCL11 and CXCL2) and adhesion molecule expression (ICAM-1 and VCAM-1).
DISCUSSION
IL-25 production by bronchial and nasal epithelial cells is regulated by transcription and protein expression, and allergen proteases can play pivotal roles in both of these biological processes. 27 NPs represent a disease the development of which is predisposed by the presence of allergen. 21 Thus our findings that epithelial cells from both human and mouse NPs induced by ovalbumin (OVA) and staphylococcal enterotoxin B (SEB) have quite high expression of IL-25 are reasonable. Regarding the cellular source of IL-25, we also observed that tryptase-positive cells were one of the abundant cell types among the infiltrating inflammatory IL-25 1 Because NPs of Asian patients are less eosinophilic compared with those of Western populations, mast cells might be involved as much as eosinophils in the mucosal pathogenesis in NPs from Asian patients. Recently, it was reported that local IgE induced by common aeroallergens might mediate mast cell activation and contribute to subsequent eosinophilic inflammation in Chinese patients with CRSwNP. 30 In Western patients with NPs, glandular mast cells and other diverse subsets of mast cells were detected more frequently in NP tissues than in UP tissues from control subjects and patients with CRS. 31 Mast cells can produce diverse cytokines related to T H 1 and T H 2, which could thus contribute to the heterogeneous inflammatory responses observed in Asian patients with CRSwNP. However, our study only demonstrates the potential engagement of mast cells in the pathogenesis of NPs in Asian patients. Therefore their exact role during nasal polypogenesis should be explored in future studies.
Our study showed increased IL-25 expression levels in human NP tissues that correlated with T-bet, RORC, and GATA-3 upregulation in patients with CRSwNP, as well as in patients with CRSsNP (data not shown). In addition, expression of transcription factors involved in T H 1/T H 2/T H 17 T-cell responses was simultaneously increased in our NP tissues (see Fig E2) . Because IL-25 is involved in diverse T H 2-mediated diseases, these mixed phenotypes and correlations between IL-25 and T H 1 and T H 17 activation markers were unexpected in our study. These mixed phenotypes of T H 1/T H 2/T H 17 pathways observed in Asian patients with NPs might be attributed to an upstream causal factor that induces diverse inflammatory cytokines, including IL-25. Alternatively, a spectrum might exist between CRSwNP and CRSsNP in Asian patients with CRS, whereas CRSwNP in Western patients is regarded as a disease entity distinct from CRSsNP. Specifically, Asian CRS subtypes can be explained by differences of severity rather than inflammatory skewing. Therefore the upregulation of IL-25 in patients with (Fig 4, C) , mucosal edema thickness (Fig 4, D) , numbers of infiltrated eosinophils (Fig 4, E) , numbers of infiltrated neutrophils (Fig 4, F) , subepithelial collagen deposition (Fig 4, G) , and numbers of goblet cells (Fig 4, H) were counted from 10 different hpfs (magnification 3400) and compared among each group (n 5 5). The Mann-Whitney U test was used to analyze the results of these experiments. *P < .05, **P < .01, and ***P < .001, Mann-Whitney U test.
J ALLERGY CLIN IMMUNOL VOLUME nnn, NUMBER nn CRSsNP and even more in patients with CRSwNP might reflect the advanced status of mixed mucosal inflammation. Interestingly, the relevance of IL-25 to the mixed inflammation pattern has been elucidated in recent reports in which patients with uncontrolled or obesity-associated asthma had mixed cytokine profiles, such as high IL-25/high IL-17A/high IL-5 levels. 32, 33 In addition, this mingled pattern was associated with neutrophilic inflammation. 33 These clinical phenotypes are similar to NPs in Asian patients in which neutrophilic infiltration was commonly observed, indicating IL-25 induction was accompanied by diverse inflammatory regulators. Lastly, a relatively weak correlation between IL-25 and TGF-b suggests that they influence each other in an indirect manner (Fig 3, E and F) .
We also used a murine NP model developed in a previous study. 34 In this model NPs were generated by means of intranasal instillation of OVA and SEB after OVA sensitization. Recent studies have used this model to evaluate epithelial remodeling, the therapeutic benefits of anti-polyp treatment, and various immunologic host characteristics. 23, [34] [35] [36] [37] NPs in this animal model showed mixed inflammation involving both eosinophilic and neutrophilic activity, which is consistent with phenotypes of NPs from Asian patients. The collagen deposition found in mouse NPs also resembled the epithelial remodeling observed in Asian patients. 38 Furthermore, the mucosal tissues in these mice showed prominent IL-25 expression similar to that observed in Korean patients with NPs. IL-25 mRNA levels were also correlated with diverse inflammatory markers in the mouse polyp model (see Fig E5 in In summary, we show that epithelial cells and infiltrating mast cells of human NPs showed prominent IL-25 expression, which positively correlated with expression of multiple inflammatory markers: T-bet, RORC, GATA3, ECP, and TGF-b. IL-25 expression was more abundant in the NP murine model compared with tissues from control mice, and anti-IL-25 treatment reduced polyp formation, mucosal thickness, collagen deposition, and infiltration of inflammatory cells, including eosinophils and neutrophils. Taken together, these findings suggest IL-25 plays a crucial role in the pathogenesis of disease in Asian patients with NPs, and blocking IL-25 activity could be a novel therapeutic strategy to improve clinical outcomes of patients with nasal polyposis.
METHODS IHC
Single IHC staining was performed by using the Polink-2 HRP Plus Broad DAB Detection System (Golden Bridge International Labs, Bothell, Wash). Briefly, after deparaffinization, the sections were incubated in 3% hydrogen peroxide for endogenous peroxidase inhibition and microwave treated in 10 mmol/L citrate buffer (pH 6.0) for heat-induced epitope retrieval. Then sections were incubated for 60 minutes at room temperature with each primary antibody, which included rabbit anti-human IL-25 (1:500, Abcam) or goat anti-human IL-17RB (1:50, R&D systems). Incubation was done in a broad antibody enhancer and polymer-horseradish peroxidase, and then sections were stained with the DAB Detection System. Finally, slides were counterstained with hematoxylin. Sequential IHC was used with polymer-horseradish peroxidase and alkaline phosphatase kits to detect mouse and rabbit primary antibodies for human tissue with permanent-Red and Emerald (Polink DS-MR-Hu C2 Kit, Golden Bridge International Labs) to identify cellular sources of IL-25. Primary antibodies against cellular phenotypic markers included mouse anti-human eosinophil major basic protein (1:50, Santa Cruz Biotechnology), mouse anti-human CD11c (1:10; BD PharMingen, San Jose, Calif), mouse anti-mast cell tryptase (1:500, Abcam), mouse anti-CD68 (1:250, Abcam), mouse anti-basophils (2D7, 1:50; Abcam), and mouse anti-human neutrophil elastase (1:100, Abcam). These antibodies were mixed with the other primary antibody, rabbit anti-human IL-25 (1:500, Abcam) was applied to the tissue, and incubation was done for 30 to 60 minutes. Polymer mixtures were made by adding alkaline phosphatase polymer anti-mouse IgG and polymer-horseradish peroxidase anti-rabbit IgG at a 1:1 ratio and applied to cover each section. Unless noted otherwise, all manufacturer's instruction was followed.
Quantitative real-time RT-PCR for inflammatory markers, chemokines, and adhesion molecules
Murine NP model and tissue preparations
The detailed experimental protocol for generating the mouse NP model was described in a previous article. E1 In brief, mice (POLYP, POLYP1aIL-25, and POLYP1steroid groups) were injected with 25 mg of OVA (Sigma, St Louis, Mo) in 2 mg of aluminum hydroxide gel administered intraperitoneally on days 0 and 5, followed by daily intranasal instillation with 3% OVA diluted in 40 mL of PBS from day 12 to day 17. Thereafter, the same amount of 3% OVA was instilled 3 times a week from day 21 to day 102. Intranasal instillation was performed in the head-down position, with the mouse's head kept down for 30 seconds after instillation to prevent pulmonary provocation. In addition, mice were challenged weekly with 10 ng of SEB (List Biological laboratories, Campbell, Calif) from day 49 through day 102 after OVA instillation. The POLYP, POLYP1aIL-25, and POLYP1steroid groups were administered weekly intraperitoneal isotype IgG (300 mg per a mouse), anti-IL-25 (300 mg per a mouse), and dexamethasone (1 mg/kg) from day 49 through day 102 before OVA instillation, respectively. Control mice (PBS) were not sensitized but administered weekly intraperitoneal isotype IgG (300 mg per a mouse) from day 49 through day 102 before OVA instillation. Mice were killed on day 103. Death occurred 24 hours after the last OVA challenge. The heads of 5 mice from each group were removed en bloc and then fixed in 4% paraformaldehyde for histopathologic analysis. After exposing the nasal cavities of the other mice, the nasal mucosa was taken out meticulously with a small curette and microforceps under microscopic vision.
Histopathologic analysis of animal tissues
For evaluation of nasal histopathology, nasal tissues were decalcified, embedded in paraffin, and sectioned coronally (4 mm thickness) approximately 5 mm from the nasal vestibule. Several stains were conducted to compare characteristics between groups: hematoxylin and eosin for polyp-like lesions, Sirius red for eosinophils, anti-neutrophilic antibody (1:50, Abcam) for neutrophils, Alcian blue for goblet cells, and Masson trichrome stain for collagen fiber in the subepithelial layer. Ten areas from nasal mucosal sections were chosen randomly for evaluation under hpfs (magnification 3400) and measured by 2 examiners who were blind to group assignment. Polyp-like lesions were defined as distinct mucosal elevations with eosinophilic infiltration and microcavity formation. Three consecutive slides were reviewed to exclude processing errors. Mucosal thickness was measured as the distance between the apex of the epithelial cells and the upper border of the subepithelial glands zone by using an image analysis system. For assessment of mucosal thickness, at least 3 measurements at random points with a minimum distance of 20 mm between the points were made in the appropriate area of each hpf, and the mean from 4 different hpfs was recorded for comparison.
Measurement of IL-25 and IL-17RB in tissue homogenates
Before ELISA, protein concentrations for tissue extracts were determined by using the Quick Start Bradford Protein Assay Kit (Bio-Rad Laboratories, Hercules, Calif). For ELISA analysis of nasal polyp tissues, 1 mL of saline solution or PBS per every 0.1 g of tissue was added to make homogenates, and homogenates were used without diluting (dilution factor 5 1). Samples were thawed at room temperature and vortexed to ensure a well-mixed sample. IL-25 (R&D Systems) and IL-17RB (R&D Systems) levels were assayed with commercially available assay kits. The minimal detection limits for these kits are 62.5 and 156 pg/mL, respectively. All procedures followed the manufacturer's recommendations. IL-25 and IL-17RB concentrations in the tissue homogenate were normalized to the concentration of total protein, as described previously. 
FIG E5.
Correlation between mRNA expression of IL-25 and inflammatory markers in the mouse polyp model. mRNA expression levels of IL-4, IL-5, IFN-g, IL-17a, TGF-b1, TGF-b2, CCL11, CCL24, CCL26, CXCL1, CXCL2, and CXCL5 were measured in nasal tissues from the mouse polyp model, and correlations between IL-25 and each inflammatory marker were investigated. Total RNA was isolated from whole sinonasal tissues from the control (n 5 10) and polyp (n 5 10) models. If the mRNA level was not detected on quantitative RT-PCR, that pair was deleted in a list-wise manner from the correlation analysis. Spearman correlation test was used, and R values indicate Spearman correlation coefficients.
